Protecting Frontline Health Care Workers (HCWs) from COVID-19 with Lambda Interferon Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Multi-Site Adaptive Trial in Toronto, Canada (HEROs Trial)
$1,000,000.00
Grant Value
2020-21
Fiscal Year
Description
Randomized study that will test the efficacy of lambda interferon to protect front line health care workers from contracting SARS-CoV-2 coronavirus which causes COVID-19 disease.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Grant Details
Recipient
University Health Network
Operating as: UHN
Location
Toronto, ON M5G 2C4
Agreement Details
Number: 947684
Reference: 172-2020-2021-Q1-947684
Timeline
Start: April 2, 2020
End: Aug. 31, 2020
Program
Industrial Research Assistance Program ? Contributions to Firms
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or …
Sector
Health care and social assistance (6221)
Your Contribution
Calculate how much you personally contributed to this grant through your taxes.
Calculate My Share